uniQure N.V. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
uniQure N.V. (QURE) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$3.41 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-08
- uniQure N.V. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$1.44M.
- uniQure N.V. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$1.97M.
- uniQure N.V. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was -$1.70M.
- uniQure N.V. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-03-31 was -$2.48M.
- uniQure N.V. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$17.79M.
- uniQure N.V. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$8.02M.
- uniQure N.V. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$23.94M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|
| 2017-06-30 | -$1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$3.41M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | -$1.97M 10-Q · filed 2017-05-09 | ||
| 2016-12-31 | -$17.79M 10-K · filed 2017-03-15 | ||
| 2016-06-30 | -$1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$4.17M 10-Q · filed 2017-08-08 | |
| 2016-03-31 | -$2.48M 10-Q · filed 2017-05-09 | ||
| 2015-12-31 | -$8.02M 10-K · filed 2017-03-15 | ||
| 2014-12-31 | -$23.94M 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |